Nakambale Hilma N, Roche Stephanie D, Mogere Peter, Omollo Victor, Kuo Alexandra P, Stergachis Andy, Baeten Jared M, Bukusi Elizabeth, Ngure Kenneth, Mugambi Melissa Latigo, Ortblad Katrina F
Department of Global Health, University of Washington, Seattle, WA, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Front Reprod Health. 2023 Feb 21;5:1023568. doi: 10.3389/frph.2023.1023568. eCollection 2023.
For individuals who face challenges accessing clinic-based HIV pre-exposure prophylaxis (PrEP), differentiated service delivery models are needed to expand access and reach. During a pilot study testing a novel pharmacy-delivered oral PrEP model in Kenya, we used routine programmatic data to identify early implementation barriers and actions that providers and study staff took in response to the barriers.
We trained pharmacy providers at five private pharmacies in Kisumu and Kiambu Counties to initiate and continue clients at risk of HIV acquisition on PrEP for a fee of 300 KES per visit (∼$3 USD) using a prescribing checklist with remote clinician oversight. Research assistants stationed at the pharmacies completed weekly observation reports of pharmacy-delivered PrEP services using a structured template. We analyzed reports from the first 6 month of implementation using content analysis and identified multi-level early implementation barriers and actions taken to address these. We then organized the identified barriers and actions according to the Consolidated Framework for Implementation Research (CFIR).
From November 2020 to May 2021, research assistants completed 74 observation reports (∼18/pharmacy). During this period, pharmacy providers screened 496 potential PrEP clients, identified 425 as eligible for pharmacy-delivered PrEP services, and initiated 230 (54%) on PrEP; 125 of 197 (63%) clients eligible for PrEP continuation refilled PrEP. We identified the following early implementation barriers to pharmacy-delivered PrEP services (by CFIR domain): high costs to clients (intervention characteristics), client discomfort discussing sexual behaviors and HIV testing with providers (outer setting), provider frustrations that PrEP delivery was time-consuming and disruptive to their workflow (inner setting), and provider hesitancy to deliver PrEP due to concerns about encouraging sexual promiscuity (characteristics of individuals). To help address these, pharmacy providers implemented a self-screening option for behavioral HIV risk assessment for prospective PrEP clients, allowed flexible appointment scheduling, and conducted pharmacy PrEP trainings for newly hired staff.
Our study provides insight into early barriers to implementing pharmacy-delivered PrEP services in Kenya and potential actions to mitigate these barriers. It also demonstrates how routine programmatic data can be used to understand the early implementation process.
对于那些在获取基于诊所的艾滋病毒暴露前预防(PrEP)方面面临挑战的个人,需要采用差异化服务提供模式来扩大可及性和覆盖范围。在肯尼亚对一种新型的由药房提供的口服PrEP模式进行试点研究期间,我们使用常规项目数据来识别早期实施障碍以及提供者和研究人员针对这些障碍所采取的行动。
我们对基苏木县和基安布县的五家私人药房的药剂师进行培训,让他们使用带有远程临床医生监督的处方清单,以每次就诊300肯尼亚先令(约3美元)的费用,为有感染艾滋病毒风险的客户启动并持续提供PrEP。驻药房的研究助理使用结构化模板完成每周一次的关于药房提供的PrEP服务的观察报告。我们使用内容分析法对实施的前6个月的报告进行分析,并确定多层次的早期实施障碍以及为解决这些障碍所采取的行动。然后,我们根据实施研究综合框架(CFIR)对确定的障碍和行动进行整理。
从2020年11月到2021年5月,研究助理完成了74份观察报告(每家药房约18份)。在此期间,药房提供者筛查了496名潜在的PrEP客户,确定其中425名有资格接受药房提供的PrEP服务,并为230名(54%)客户启动了PrEP;在197名有资格继续接受PrEP的客户中,有125名(63%)重新填充了PrEP。我们确定了以下药房提供PrEP服务的早期实施障碍(按CFIR领域划分):客户成本高(干预特征)、客户在与提供者讨论性行为和艾滋病毒检测时感到不适(外部环境)、提供者因PrEP服务耗时且扰乱其工作流程而感到沮丧(内部环境)以及提供者因担心鼓励性乱交而对提供PrEP犹豫不决(个人特征)。为帮助解决这些问题,药房提供者为潜在的PrEP客户实施了行为艾滋病毒风险评估的自我筛查选项,允许灵活安排预约,并为新员工开展药房PrEP培训。
我们的研究深入了解了在肯尼亚实施药房提供的PrEP服务的早期障碍以及减轻这些障碍的潜在行动。它还展示了如何利用常规项目数据来理解早期实施过程。